Is there any good analysis of that? I'm not saying it's not "profiteering", I just find it puzzling that nobody had undercut them on prices yet. There must be a

Is there any good analysis of that? I'm not saying it's not "profiteering", I just find it puzzling that nobody had undercut them on prices yet. There must be a reason, and health care is very complicated, so I'm not even trying to generate hypotheses on my own (I'm definitely not qualified for that). I have little hope that those "hearings" will actually find the root cause of the problem. Related: see the old Martin Shkreli videos where he ruthlessly goes over the list of all drugs to find something where his company/companies can undercut the pricing of the status quo, looking for the highest margin profit potential / assumed fixed cost ratios. He is (well, was) obviously not the only one.